Chronic Obstructive Pulmonary Disease News and Research

Latest Chronic Obstructive Pulmonary Disease News and Research

Small breathing device could improve respiratory health and fitness levels of people with long COVID

New research presented at The Physiological Society's Long COVID: Mechanisms, Risk Factors, and Recovery on 22 – 23 February shows that a small handheld breathing device helped reduced breathlessness and improved physical fitness of people with long COVID.

23 Feb 2022

Inmates who died asked for release before falling ill with covid

Rory Adams did not know that Christmas in a small rural hospital in West Virginia would be the last time he saw his wife alive. She'd entered prison in early January 2021 to serve a 42-month sentence for failure to collect payroll taxes.

18 Feb 2022

As covid slogs on, seniors find fortitude waning and malaise growing

Late one night in January, Jonathan Coffino, 78, turned to his wife as they sat in bed. "I don't know how much longer I can do this," he said, glumly.

18 Feb 2022

UC joins nationwide trial to evaluate efficacy of repurposed drugs for mild-to-moderate COVID-19

The University of Cincinnati is joining a nationwide study to evaluate repurposed medications in the search for effective, safe treatments for mild-to-moderate COVID-19. Repurposed medications are those already approved by the U.S. Food and Drug Administration for other indications.

16 Feb 2022

Regular physical activity at 70 may help ward off heart disease in old age

Twenty minutes of daily moderate to vigorous exercise in early old age (70-75) may best stave off major heart disease, including heart failure, in late old age (80+), suggests research published online in the journal Heart.

15 Feb 2022

Liver cirrhosis has higher hospitalization and in-hospital mortality rates in Germany

In Germany, liver cirrhosis has the highest mortality rate of any chronic disease requiring hospital admission. When diagnosed as a comorbidity of other chronic diseases, liver cirrhosis at least doubles the mortality rate.

12 Feb 2022

COPD patients more compliant with COVID-19 restrictions in the UK

A new study reports on the tendency among COPD patients in the UK to practice social distancing, compared to the public at large, during the COVID-19 pandemic.

11 Feb 2022

Association between SARS-CoV-2 infection and several key respiratory and non-respiratory complications

Researchers assessed the intensity of association between SARS-CoV-2 infection and risks of various respiratory and non-respiratory complications.

9 Feb 2022

Reviewing breath biomarkers for inflammatory respiratory diseases

The prevalence of inflammatory airway diseases such as lung cancer, chronic obstructive pulmonary disease (COPD) and asthma is on the rise internationally, placing strain on health systems around the world. Lung cancer is the leading cause of death of all cancers.

From Owlstone Medical Ltd 8 Feb 2022

Study shows positive outcomes in COVID-19 patients who underwent lung transplants

For many COVID-19 patients with irrecoverable lung damage, transplantation is the only option for survival. However, there is limited information about the long-term outcomes of these patients, including postoperative complications, hospital length of stay and survival.

3 Feb 2022

Simple screening method could reduce the occurrence of lung diseases

Deaths from common lung diseases are on the rise in Sub-Saharan Africa but a simple screening method could significantly reduce their occurrence in the region, a study says.

3 Feb 2022

Study finds link between lifetime workplace exposure to pesticides and elevated COPD risk

Lifetime workplace exposure to pesticides is linked to a heightened risk of COPD, the umbrella term for a group of respiratory diseases that cause airflow blockage and breathing problems, finds a large population based study, published online in the journal Thorax.

26 Jan 2022

Spike-mediated CFTR inhibition accounts for airway inflammation in COVID-19

A new study looks at the molecular level inhibition of the protective CFTR gene by the SARS-CoV-2 spike protein.

25 Jan 2022

Meta-analysis confirms complete failure of hydroxychloroquine/chloroquine as a COVID-19 treatment

Researchers investigate the efficacy of hydroxychloroquine and chloroquine in the treatment of patients hospitalized with COVID-19.

17 Jan 2022

COPD: Ion channels in immune cells could potentially be targets for new therapies

Chronic obstructive pulmonary disease – COPD for short – is one of the most common diseases of the lung. It affects almost 300 million people worldwide, of which about three million die every year.

17 Jan 2022

Composition of microbes in the lower airways is different for patients with idiopathic pulmonary fibrosis

A new study from the University of Bergen shows that patients with Idiopathic pulmonary fibrosis (IPF) have a different composition of microbes in the lower airways than healthy controls and patients with Chronic obstructive pulmonary disease (COPD).

13 Jan 2022

Role of leptin in immune modulation and pathophysiology of COVID-19

A recent review paper in the journal Frontiers in Physiology discusses the role of leptins in infection with SARS-CoV-2 that triggered the ongoing COVID-19 pandemic.

13 Jan 2022

Simple health assessment could significantly reduce the global burden of COPD

The global burden of Chronic Obstructive Pulmonary Disease (COPD), a group of common lung conditions that affects more than 300 million people, could be significantly reduced with a simple health assessment, concludes a large-scale international study led by UCL researchers.

11 Jan 2022

New study identifies ways to detect COPD in low- and middle-income countries

How to better detect chronic obstructive pulmonary disease (COPD) in low- and middle-income countries is a question that has long plagued the global medical community.

11 Jan 2022

A new model for predicting COVID-19 severity at diagnosis

Researchers estimate the probabilities of hospitalization and mortality from COVID-19 according to individual risk factors and number of vaccine doses.

5 Jan 2022

Chronic Obstructive Pulmonary Disease News and Research

Latest Chronic Obstructive Pulmonary Disease News and Research

Small breathing device could improve respiratory health and fitness levels of people with long COVID

Inmates who died asked for release before falling ill with covid

As covid slogs on, seniors find fortitude waning and malaise growing

UC joins nationwide trial to evaluate efficacy of repurposed drugs for mild-to-moderate COVID-19

Regular physical activity at 70 may help ward off heart disease in old age

Liver cirrhosis has higher hospitalization and in-hospital mortality rates in Germany

COPD patients more compliant with COVID-19 restrictions in the UK

Association between SARS-CoV-2 infection and several key respiratory and non-respiratory complications

Reviewing breath biomarkers for inflammatory respiratory diseases

Study shows positive outcomes in COVID-19 patients who underwent lung transplants

Simple screening method could reduce the occurrence of lung diseases

Study finds link between lifetime workplace exposure to pesticides and elevated COPD risk

Spike-mediated CFTR inhibition accounts for airway inflammation in COVID-19

Meta-analysis confirms complete failure of hydroxychloroquine/chloroquine as a COVID-19 treatment

COPD: Ion channels in immune cells could potentially be targets for new therapies

Composition of microbes in the lower airways is different for patients with idiopathic pulmonary fibrosis

Role of leptin in immune modulation and pathophysiology of COVID-19

Simple health assessment could significantly reduce the global burden of COPD

New study identifies ways to detect COPD in low- and middle-income countries

A new model for predicting COVID-19 severity at diagnosis

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Chronic Obstructive Pulmonary Disease News and Research

Latest Chronic Obstructive Pulmonary Disease News and Research

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Newsletters you may be interested in